Cargando…

Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis

Background: Minimal residual disease (MRD) has shown the prognostic value in mantle cell lymphoma (MCL). To quantify the relationships between progression free survival (PFS) and overall survival (OS) with MRD status in MCL, we conducted this meta-analysis. Methods: We searched databases including P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yu, Chen, Haizhu, Tao, Yunxia, Zhong, Qiaofeng, Shi, Yuankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738989/ https://www.ncbi.nlm.nih.gov/pubmed/33391451 http://dx.doi.org/10.7150/jca.51959

Ejemplares similares

The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
por: Zhong, Qiaofeng, et al.
Publicado: (2021)

Advances in the assessment of minimal residual disease in mantle cell lymphoma
por: Jung, Dayoung, et al.
Publicado: (2020)

Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
por: Zhong, Qiaofeng, et al.
Publicado: (2021)

The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005–2020): A systematic review
por: Chen, Haizhu, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis
por: Feng, Yu, et al.
Publicado: (2023)

Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis
por: Qian, Xiaoyan, et al.
Publicado: (2023)

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
por: Castellino, Alessia, et al.
Publicado: (2022)

Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma
por: Tan, Jing Yuan, et al.
Publicado: (2021)

Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era
por: Chen, Haizhu, et al.
Publicado: (2022)

Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy
por: Zhou, Yu, et al.
Publicado: (2021)

ZGDHu-1 promotes apoptosis of mantle cell lymphoma cells
por: Qiu, Liannv, et al.
Publicado: (2016)

Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma
por: Kang, Byung Woog, et al.
Publicado: (2014)

High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
por: Yi, Shuhua, et al.
Publicado: (2015)

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
por: Vallumsetla, Nishanth, et al.
Publicado: (2015)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
por: LeBlanc, Francis R., et al.
Publicado: (2022)

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1
por: Sekihara, Kazumasa, et al.
Publicado: (2017)

Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma
por: Zhu, Yuandong, et al.
Publicado: (2019)

EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
por: Martinez-Baquero, Diana, et al.
Publicado: (2021)

Metachronous Sigmoid Carcinoma and Mantle Cell Lymphoma in Intestines
por: Yu, Qiao, et al.
Publicado: (2019)

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma
por: Leshchenko, Violetta V., et al.
Publicado: (2015)

Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma
por: Miao, Yi, et al.
Publicado: (2019)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population
por: Yang, Xinyi, et al.
Publicado: (2021)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Mantle cell lymphoma with skin involvement
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2015)

Esophageal location of mantle cell lymphoma
por: Michopoulos, Spyros
Publicado: (2016)

Tracheobronchial involvement of mantle cell lymphoma
por: Tong, Lin, et al.
Publicado: (2018)

Mantle Cell Lymphoma Case Report
por: Podzolkov, V.I., et al.
Publicado: (2018)

Educational Case: Mantle Cell Lymphoma
por: Mai, Brenda, et al.
Publicado: (2020)

Emerging therapies in mantle cell lymphoma
por: Hanel, Walter, et al.
Publicado: (2020)

Tackling Mantle Cell Lymphoma in Europe
por: Horgan, Denis, et al.
Publicado: (2022)

Maintenance Treatment for Patients With Mantle Cell Lymphoma: A Systematic Review and Meta-analysis of Randomized Trials
por: Vidal, Liat, et al.
Publicado: (2018)

Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling
por: Pighi, Chiara, et al.
Publicado: (2011)

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma
por: Rosich, Laia, et al.
Publicado: (2014)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
por: Morello, Lucia, et al.
Publicado: (2019)

Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas
por: Yim, Rita Lh, et al.
Publicado: (2014)

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
por: Lakhotia, Rahul, et al.
Publicado: (2022)

Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
por: Narkhede, Mayur, et al.
Publicado: (2022)

Autologous stem cell transplantation for mantle cell lymphoma – single centre experience
por: Szcześniak, Magdalena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uoqo9j2q908hf4m0rhes76kiku